Research, development, production and distribution of nutritional health supplements,
dermocosmetics, dietary foods for special medical purposes and medical devices
<a href="/events">We will be present </a>
<a href="/about-us/quality">Certified quality</a>

Amnol is committed to maintaining the quality of its products and manufacturing processes, proven by n.6860A ISO 9001:2008 certification. The company guarantees excellence in its nutritional health supplements, dermocosmetics and medical devices by means of scrupulous methods of control and state of the art instruments, thus safeguarding the well-being of end-users.

<a href="/expert">Ask the expert</a>

Our experts are at your disposal for any enquiries you may have regarding Amnol's products and will respond to your requests for any further information or informative literature. Please contact them by email or call on our toll free number.

News from the world

News from the world

  • Long-term follow-up results of patients undergoing...
    Authors: Hurst K, Handa A PMID: 28325135 [PubMed - in process] (Source: Phlebology)
  • Recommendations for the medical management of chro...
    Conclusion In summary, the general level of evidence supports the recommendation that the use of medical therapy with Micronized P...
  • Summaries of recent phlebological abstracts.
    Authors: Kabnick L, Almeida J PMID: 28164749 [PubMed - in process] (Source: Phlebology)
  • A case-control study of risk factors of chronic ve...
    Conclusion We found that reflux in deep veins, history of leg injury, history of post thrombotic syndrome, and physical inactivity...
  • Valsalva maneuver in phlebologic practice.
    Authors: Ricci S, Moro L, Minotti GC, Incalzi RA, De Maeseneer M Abstract Forced expiration against an airway obstruction ...
  • Patients and physicians agree only partially in sy...
    Conclusion The Aberdeen Varicose Vein Questionnaire has added valuable information to the dialogue between the doctor and patient ...
  • Lower limbs venous kinetics and consequent impact ...
    Conclusion This investigation provides evidences of the velocity decrease from the deepest to the most superficial compartments. T...
  • Clinical implications of the anatomical variation ...
    Conclusion Lower limb DVTs are more common at the left side; however, patients with bilateral DVT have higher frequency of recurre...
  • Effective anti-DVT prophylaxis in patients undergo...
    Authors: Nyamekye IK PMID: 28056698 [PubMed - as supplied by publisher] (Source: Phlebology)
  • Functional chronic venous disease: A systematic re...
    Conclusions Functional chronic venous disease is a complex syndrome and further evidences are needed in order to assess the pathop...
Newsletter

Newsletter

Sign up to our newsletter to keep up-to-date about what's new at AMNOL.








AMNOL Chimica Biologica S.r.l.
Registered office, Administrative and Sales Offices: Corso della Vittoria 14, 28100 Novara
Tel: +39 0321 499199 - Email: info@amnol.net
Share Capital € 250,000 issued capital R.E.A. Novara 10937 VAT code 01228730030 Tax Code 04170400156



AMNOL Chimica Biologica and Euronational are companies of the WTB group (company subject to management and co-ordination activity pursuant to Art.2497 CC by WTB Holding S.p.A. - Milan)


Quality Management System Certified by KIWA CERMET according to the UNI EN ISO 9001:2008 Reg No. 6860-A.

Copyright 2017 by Amnol Chimica Biologica